Accordingly, downregulation of ERK phosphorylation (pERK) was shown to be most effective in response to a daily dose of 300 mg dabrafenib, whereas elevated doses of 400 mg and 600 mg, respectively, only presented with reduced pERK inhibition, as determined in human melanoma tissue samples [6]. This evidence concerns the gene EIF2AK3 and melanoma.